Tirzepatide
Dual GIP / GLP-1 Receptor Agonist
GLP-1 Receptor Agonist Analog
A long-acting GLP-1 analog used as a reference standard in incretin and metabolic-signalling research.
Sold for laboratory research use only. Not for human or veterinary use.
Semaglutide is a GLP-1 receptor agonist analog featuring an Aib8 substitution and a C18 fatty-acid side chain that extends half-life. It is supplied for in-vitro receptor-binding, incretin-signalling and metabolic-model research.
Purity is verified by RP-HPLC at 220 nm and identity by ESI-MS. The COA includes the full amino-acid sequence and the fatty-acid modification site.
Store lyophilised powder at −20 °C. Protect from light and moisture. Reconstituted solution: 2–8 °C, use within 28 days.
Each lot is released against a written specification. The certificate of analysis supplied with your order includes the HPLC chromatogram, calculated purity, mass-spectrometry result and the theoretical versus observed molecular weight.